Back
Arrowhead Pharmaceuticals Stock Price Chart
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Sell
20
ARWR
Arrowhead Pharmaceuticals
Last Price:
22.11
Seasonality Move:
3.08%
7 Day Trial
ALL ACCESS PASS
$
7
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARWR is experiencing slight selling pressure.
Arrowhead Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23 | Sell |
| 20-day SMA: | 24.86 | Sell |
| 50-day SMA: | 28.15 | Sell |
| 200-day SMA: | 29.08 | Sell |
| 8-day EMA: | 23.25 | Sell |
| 20-day EMA: | 24.7 | Sell |
| 50-day EMA: | 27.14 | Sell |
| 200-day EMA: | 29.65 | Sell |
Arrowhead Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.62 | Sell |
| Relative Strength Index (14 RSI): | 30.74 | Sell |
| Chaikin Money Flow: | -354801 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.4 - 27.56) | Sell |
| Bollinger Bands (100): | (25.53 - 33.77) | Sell |
Arrowhead Pharmaceuticals Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arrowhead Pharmaceuticals Stock
Is Arrowhead Pharmaceuticals Stock a Buy?
- Arrowhead Pharmaceuticals share price is 21.87 while ARWR 8-day simple moving average is 23.00, which is a Sell signal.
- The stock price of ARWR is 21.87 while Arrowhead Pharmaceuticals 20-day SMA is 24.86, which makes it a Sell.
- Arrowhead Pharmaceuticals 50-day simple moving average is 28.15 while ARWR share price is 21.87, making it a Sell technically.
- ARWR stock price is 21.87 and Arrowhead Pharmaceuticals 200-day simple moving average is 29.08, creating a Sell signal.
ARWR Technical Analysis vs Fundamental Analysis
Sell
20
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy or a Sell?
-
Arrowhead Pharmaceuticals stock is rated a Sell
The current Arrowhead Pharmaceuticals [ARWR] share price is $21.87. The Score for ARWR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Arrowhead Pharmaceuticals Stock Info
Market Cap:
2.71B
Price in USD:
21.87
Share Volume:
974.09K
Arrowhead Pharmaceuticals 52-Week Range
52-Week High:
42.48
52-Week Low:
20.67
Sell
20
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Arrowhead Pharmaceuticals Share Price Forecast
-
What is the Arrowhead Pharmaceuticals stock price today?
The Arrowhead Pharmaceuticals stock price is 21.87 USD today. -
Will ARWR stock go up or go down?
Arrowhead Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Arrowhead Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arrowhead Pharmaceuticals is overvalued.
Is Arrowhead Pharmaceuticals Stock a Buy?
- Arrowhead Pharmaceuticals share price is 21.87 while ARWR 8-day exponential moving average is 23.25, which is a Sell signal.
- The stock price of ARWR is 21.87 while Arrowhead Pharmaceuticals 20-day EMA is 24.70, which makes it a Sell.
- Arrowhead Pharmaceuticals 50-day exponential moving average is 27.14 while ARWR share price is 21.87, making it a Sell technically.
- ARWR stock price is 21.87 and Arrowhead Pharmaceuticals 200-day simple moving average is 29.65, creating a Sell signal.
Fundamental Analysis of Arrowhead Pharmaceuticals
Is Arrowhead Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.03 per share, a decrease this year of $1.27 per share, and an increase next year of $0.08 per share.
Technical Analysis of Arrowhead Pharmaceuticals
Should I short Arrowhead Pharmaceuticals stock?
- ARWR Moving Average Covergence Divergence (MACD) indicator is -1.62, suggesting Arrowhead Pharmaceuticals is a Sell
- Arrowhead Pharmaceuticals Relative Strength Index (RSI) is 30.74, which suggest Arrowhead Pharmaceuticals is oversold
- The Bollinger Bands (25) for Arrowhead Pharmaceuticals is (23.4 - 27.56), which suggest Arrowhead Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Arrowhead Pharmaceuticals is (25.53 - 33.77), which suggest Arrowhead Pharmaceuticals is a Sell
* Arrowhead Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.